1. Home
  2. CLDX vs OPRA Comparison

CLDX vs OPRA Comparison

Compare CLDX & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • OPRA
  • Stock Information
  • Founded
  • CLDX 1983
  • OPRA 1996
  • Country
  • CLDX United States
  • OPRA Norway
  • Employees
  • CLDX N/A
  • OPRA N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • OPRA Computer Software: Prepackaged Software
  • Sector
  • CLDX Health Care
  • OPRA Technology
  • Exchange
  • CLDX Nasdaq
  • OPRA Nasdaq
  • Market Cap
  • CLDX 1.7B
  • OPRA 1.6B
  • IPO Year
  • CLDX 2008
  • OPRA 2018
  • Fundamental
  • Price
  • CLDX $22.46
  • OPRA $19.59
  • Analyst Decision
  • CLDX Buy
  • OPRA Strong Buy
  • Analyst Count
  • CLDX 8
  • OPRA 5
  • Target Price
  • CLDX $61.86
  • OPRA $24.80
  • AVG Volume (30 Days)
  • CLDX 774.1K
  • OPRA 433.2K
  • Earning Date
  • CLDX 03-04-2025
  • OPRA 02-27-2025
  • Dividend Yield
  • CLDX N/A
  • OPRA 7.96%
  • EPS Growth
  • CLDX N/A
  • OPRA 142.24
  • EPS
  • CLDX N/A
  • OPRA 1.78
  • Revenue
  • CLDX $9,976,000.00
  • OPRA $447,818,000.00
  • Revenue This Year
  • CLDX N/A
  • OPRA $21.46
  • Revenue Next Year
  • CLDX N/A
  • OPRA $15.79
  • P/E Ratio
  • CLDX N/A
  • OPRA $11.03
  • Revenue Growth
  • CLDX 128.55
  • OPRA 17.82
  • 52 Week Low
  • CLDX $20.91
  • OPRA $10.11
  • 52 Week High
  • CLDX $53.18
  • OPRA $22.50
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 42.55
  • OPRA 48.32
  • Support Level
  • CLDX $22.38
  • OPRA $20.67
  • Resistance Level
  • CLDX $23.69
  • OPRA $22.50
  • Average True Range (ATR)
  • CLDX 1.07
  • OPRA 0.94
  • MACD
  • CLDX 0.03
  • OPRA 0.00
  • Stochastic Oscillator
  • CLDX 44.67
  • OPRA 46.90

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About OPRA Opera Limited

Opera Ltd is a world-wide internet brand with a large, engaged and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. The newest addition of browsers is the beta release of a Web3-centric browser for PC and mobile which is tailored for crypto enthusiasts.

Share on Social Networks: